1Dubuske LM. Second - generation antihistamines : the risk of ventricular arrhythmias[J]. Clin Ther, 1999;21:281 -295.
2Paakkari I. Cardiotoxicity of new antihistamines and cisapride [ J ]. Toxocol Lett ,2002 ; 127:279 - 284.
3Tong K. L, Lau YS, Teo WS. A case series of drug - induced long QT syndrome and torsade de pointes [ J ]. Singapore Med J, 2001 ;42:566 - 570.
4Zehser D, Justo D , Halkin A. et al. Torsade de pointes due to non-cardiac drugs: most patients have easily identifiable risk factors [ J ]. Medicine, 2003 ;82:282 - 290.
5Staff JA, Jones JK, Gable CB, et al. Risk of selected serious cardiac events among new users of antihistamines [J]. Clin Ther, 1995 ; 17 : 1062 - 1077.
6Delgado LF, Pferferman A, Sole D. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children [J]. Ann Allergy Asthma Immunol, 1998; 80:333 - 337.
7De Ponti F, Poluzzi E, Montanaro N. QT - interval prolongation by non -cardiac drugs: lessons to be learned from recent experience[J]. Eur J Clin Pharmacol,2000 ;56 : 1 - 18.
